Shanghai Kinetic Medical Co - Asset Resilience Ratio
Shanghai Kinetic Medical Co (300326) has an Asset Resilience Ratio of 28.89% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Shanghai Kinetic Medical Co to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Shanghai Kinetic Medical Co's Asset Resilience Ratio has changed over time. See how leveraged is Shanghai Kinetic Medical Co's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Kinetic Medical Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300326 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥976.00 Million | 28.89% |
| Total Liquid Assets | CN¥976.00 Million | 28.89% |
Asset Resilience Insights
- Very High Liquidity: Shanghai Kinetic Medical Co maintains exceptional liquid asset reserves at 28.89% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Kinetic Medical Co Industry Peers by Asset Resilience Ratio
Compare Shanghai Kinetic Medical Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for Shanghai Kinetic Medical Co (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Shanghai Kinetic Medical Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 25.11% | CN¥841.43 Million ≈ $123.13 Million |
CN¥3.35 Billion ≈ $490.33 Million |
+12.55pp |
| 2023-12-31 | 12.56% | CN¥421.23 Million ≈ $61.64 Million |
CN¥3.35 Billion ≈ $490.80 Million |
+4.81pp |
| 2022-12-31 | 7.75% | CN¥264.40 Million ≈ $38.69 Million |
CN¥3.41 Billion ≈ $499.30 Million |
+2.68pp |
| 2021-12-31 | 5.07% | CN¥177.80 Million ≈ $26.02 Million |
CN¥3.51 Billion ≈ $513.55 Million |
+0.41pp |
| 2020-12-31 | 4.66% | CN¥171.46 Million ≈ $25.09 Million |
CN¥3.68 Billion ≈ $538.62 Million |
+2.01pp |
| 2019-12-31 | 2.65% | CN¥99.82 Million ≈ $14.61 Million |
CN¥3.77 Billion ≈ $551.69 Million |
+1.70pp |
| 2018-12-31 | 0.95% | CN¥33.80 Million ≈ $4.95 Million |
CN¥3.57 Billion ≈ $522.37 Million |
-6.03pp |
| 2017-12-31 | 6.98% | CN¥188.00 Million ≈ $27.51 Million |
CN¥2.69 Billion ≈ $394.29 Million |
+5.40pp |
| 2016-12-31 | 1.58% | CN¥35.00 Million ≈ $5.12 Million |
CN¥2.22 Billion ≈ $324.41 Million |
+0.87pp |
| 2015-12-31 | 0.71% | CN¥12.00 Million ≈ $1.76 Million |
CN¥1.70 Billion ≈ $248.14 Million |
-0.05pp |
| 2014-12-31 | 0.76% | CN¥10.00 Million ≈ $1.46 Million |
CN¥1.31 Billion ≈ $192.07 Million |
-- |
About Shanghai Kinetic Medical Co
Shanghai Kinetic Medical Co., Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of medical devices in China and internationally. The company offers invasive spinal, invasive vertebroplasty, radiofrequency ablation, orthopedic trauma implant equipment, artificial organs, orthopedic surgical instruments, and other medical products, as well as surgica… Read more